Scottsdale, AZ, March 24, 2014 – Women undergoing a hysterectomy who received intraoperative intravenous acetaminophen require significantly less recovery time, according to researchers at Summa Health System in Akron, Ohio.
Dr. Bradford Fenton, M.D., Ph.D. of Summa’s Department of Obstetrics and Gynecology and his colleagues examined the medical records of 966 women who underwent hysterectomy between January 1, 2010, and July 1, 2013, for both benign conditions and gynecologic malignancies. Patients were grouped according to whether intraoperative intravenous acetaminophen was given or not. Anti-nausea and anti-inflammatory drug administrations, as well as Post-Anesthesia Care Unit (PACU) length of stay, were abstracted for the study.
Patients were divided equally between groups, which were statistically equivalent for demographic information, including age, marital status, insurance, body mass index and type of hysterectomy, including total abdominal, laparoscopic-assisted vaginal and robotic.
Although the study found no significant difference in opioid consumption between the two groups, receiving the IV acetaminophen positively affected many other measures of patient recovery, and average recovery time was more than six minutes shorter for those in the IV acetaminophen group. Administration of anti-nausea and anti-inflammatory drugs in the PACU was also significantly lower with the group of women who were given the acetaminophen during surgery.
Dr. Jenifer Lessick, D.O., co-investigator, will speak on these findings at the 40th Annual Scientific Meeting of the Society of Gynecologic Surgeons March 23-26 in Scottsdale, Arizona. Her oral plenary presentation will be held at 12:55 p.m. on March 24.
About Summa Health System
Summa Health System is one of the largest integrated healthcare delivery systems in Ohio. Encompassing a network of hospitals, community health centers, a health plan, a physician-hospital organization, a multi-specialty physician organization, research and multiple foundations, Summa is nationally renowned for excellence in patient care and for exceptional approaches to healthcare delivery. Summa's clinical services are consistently recognized by the American Nurses Credentialing Center (Magnet status), U.S. News and World Report, Thomson Reuters and The Leapfrog Group. Summa also is a founding partner of the Austen BioInnovation Institute in Akron. For more information, visit www.summahealth.org or find us on Facebook at www.facebook.com/summahealth and Twitter at www.twitter.com/summahealth.